{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:57:14Z","timestamp":1789988234663,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,25]],"date-time":"2014-12-25T00:00:00Z","timestamp":1419465600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00296-014-3194-9","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:53:20Z","timestamp":1419382400000},"page":"1059-1067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Glucocorticoid use is associated with increase in HDL and no change in other lipids in rheumatoid arthritis patients"],"prefix":"10.1007","volume":"35","author":[{"given":"Lisa L.","family":"Schroeder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Chester M.","family":"Wasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Androniki","family":"Bili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,25]]},"reference":[{"key":"3194_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","volume":"58","author":"CG Helmick","year":"2008","unstructured":"Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK et al (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the united states. Part I. Arthritis Rheum 58:15\u201325","journal-title":"Arthritis Rheum"},{"key":"3194_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s11926-008-0063-0","volume":"10","author":"MC Wasko","year":"2008","unstructured":"Wasko MC (2008) Rheumatoid arthritis and cardiovascular disease. Curr Rheumatol Rep 10:390\u2013397","journal-title":"Curr Rheumatol Rep"},{"key":"3194_CR3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.1780370408","volume":"37","author":"F Wolfe","year":"1994","unstructured":"Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA et al (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481\u2013494","journal-title":"Arthritis Rheum"},{"key":"3194_CR4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","volume":"48","author":"SE Gabriel","year":"2003","unstructured":"Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O\u2019Fallon WM et al (2003) Survival in rheumatoid arthritis: a population-based analysis of trends over 40\u00a0years. Arthritis Rheum 48:54\u201358","journal-title":"Arthritis Rheum"},{"key":"3194_CR5","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","volume":"59","author":"JA Avi\u00f1a-Zubieta","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690\u20131697","journal-title":"Arthritis Rheum"},{"key":"3194_CR6","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","volume":"44","author":"ID Rincon del","year":"2001","unstructured":"del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 44:2737\u20132745","journal-title":"Arthritis Rheum"},{"key":"3194_CR7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE et al (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107:1303\u20131307","journal-title":"Circulation"},{"key":"3194_CR8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016110791112269","volume":"8","author":"TE Toms","year":"2010","unstructured":"Toms TE, Symmons DP, Kitas GD (2010) Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol 8:301\u2013326","journal-title":"Curr Vasc Pharmacol"},{"key":"3194_CR9","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/archinte.1987.00370110040005","volume":"147","author":"KL Svenson","year":"1987","unstructured":"Svenson KL, Lithell H, Hallgren R, Selinus I, Vessby B (1987) Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. relativity to inflammatory activity. Arch Intern Med 147:1912\u20131916","journal-title":"Arch Intern Med"},{"key":"3194_CR10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/PL00011174","volume":"19","author":"YH Lee","year":"2000","unstructured":"Lee YH, Choi SJ, Ji JD, Seo HS, Song GG (2000) Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol 19:324\u2013325","journal-title":"Clin Rheumatol"},{"key":"3194_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/MED.0b013e3282f79b0b","volume":"15","author":"F Majeed","year":"2008","unstructured":"Majeed F, Miller M (2008) Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessment. Curr Opin Endocrinol Diabetes Obes 15:175\u2013181","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3194_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.ATV.17.1.107","volume":"17","author":"U Goldbourt","year":"1997","unstructured":"Goldbourt U, Yaari S, Medalie JH (1997) Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. a 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 17:107\u2013113","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3194_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0009-8981(02)00046-3","volume":"320","author":"A Salazar","year":"2002","unstructured":"Salazar A, Mana J, Pinto X, Argimon JM, Hurtado I, Pujol R (2002) Corticosteroid therapy increases HDL-cholesterol concentrations in patients with active sarcoidosis and hypoalphalipoproteinemia. Clin Chim Acta 320:59\u201364","journal-title":"Clin Chim Acta"},{"key":"3194_CR14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","volume":"62","author":"M Boers","year":"2003","unstructured":"Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE et al (2003) Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. Ann Rheum Dis 62:842\u2013845","journal-title":"Ann Rheum Dis"},{"key":"3194_CR15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/ard.2006.059691","volume":"66","author":"MJ Peters","year":"2007","unstructured":"Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF et al (2007) Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis 66:958\u2013961","journal-title":"Ann Rheum Dis"},{"key":"3194_CR16","first-page":"867","volume":"31","author":"PH Dessein","year":"2004","unstructured":"Dessein PH, Joffe BI, Stanwix AE, Christian BF, Veller M (2004) Glucocorticoids and insulin sensitivity in rheumatoid arthritis. J Rheumatol 31:867\u2013874","journal-title":"J Rheumatol"},{"key":"3194_CR17","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.22053","volume":"54","author":"PH Dessein","year":"2006","unstructured":"Dessein PH, Joffe BI (2006) Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 54:2765\u20132775","journal-title":"Arthritis Rheum"},{"key":"3194_CR18","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar428","volume":"4","author":"PH Dessein","year":"2002","unstructured":"Dessein PH, Stanwix AE, Joffe BI (2002) Cardiovascular risk in rheumatoid arthritis versus osteoarthritis: acute phase response related decreased insulin sensitivity and high-density lipoprotein cholesterol as well as clustering of metabolic syndrome features in rheumatoid arthritis. Arthritis Res 4:R5","journal-title":"Arthritis Res"},{"key":"3194_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0026-0495(98)90005-1","volume":"37","author":"KL Svenson","year":"1988","unstructured":"Svenson KL, Pollare T, Lithell H, Hallgren R (1988) Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance. Metabolism 37:125\u2013130","journal-title":"Metabolism"},{"key":"3194_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/acr.20414","volume":"63","author":"MC Wasko","year":"2011","unstructured":"Wasko MC, Kay J, Hsia EC, Rahman MU (2011) Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease. Arthritis Rheum 63:512\u2013521","journal-title":"Arthritis Rheum"},{"key":"3194_CR21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acr.20657","volume":"64","author":"JL Antohe","year":"2012","unstructured":"Antohe JL, Bili A, Sartorius JA, Kirchner HL, Morris SJ, Dancea S et al (2012) Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor alpha therapy. Arthritis Care Res 64:215\u2013221","journal-title":"Arthritis Care Res"},{"key":"3194_CR22","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/art.22418","volume":"56","author":"JM Davis","year":"2007","unstructured":"Davis JM, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM et al (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56:820\u2013830","journal-title":"Arthritis Rheum"},{"key":"3194_CR23","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.20661","volume":"50","author":"I Rincon del","year":"2004","unstructured":"del Rincon I, O\u2019Leary DH, Haas RW, Escalante A (2004) Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 50:3813\u20133822","journal-title":"Arthritis Rheum"},{"key":"3194_CR24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/ard.2009.115717","volume":"69","author":"TE Toms","year":"2010","unstructured":"Toms TE, Panoulas VF, Douglas KM, Griffiths H, Sattar N, Smith JP et al (2010) Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 69:683\u2013688","journal-title":"Ann Rheum Dis"},{"key":"3194_CR25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/archinte.1987.00370110045006","volume":"147","author":"KL Svenson","year":"1987","unstructured":"Svenson KL, Lithell H, Hallgren R, Vessby B (1987) Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment. Arch Intern Med 147:1917\u20131920","journal-title":"Arch Intern Med"},{"key":"3194_CR26","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9343(02)01186-5","volume":"113","author":"YB Park","year":"2002","unstructured":"Park YB, Choi HK, Kim MY, Lee WK, Song J, Kim DK et al (2002) Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study.See comment. Am J Med 113:188\u2013193","journal-title":"Am J Med"},{"key":"3194_CR27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-9343(90)90345-E","volume":"89","author":"DJ Wallace","year":"1990","unstructured":"Wallace DJ, Metzger AL, Stecher VJ, Turnbull BA, Kern PA (1990) Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. Am J Med 89:322\u2013326","journal-title":"Am J Med"},{"key":"3194_CR28","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar1952","volume":"8","author":"AN Georgiadis","year":"2006","unstructured":"Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD et al (2006) Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment\u2014a prospective, controlled study. Arthritis Res Ther 8:R82","journal-title":"Arthritis Res Ther"},{"key":"3194_CR29","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/jama.298.7.786","volume":"298","author":"IM Singh","year":"2007","unstructured":"Singh IM, Shishehbor MH, Ansell BJ (2007) High-density lipoprotein as a therapeutic target: a systematic review. JAMA 298:786\u2013798","journal-title":"JAMA"},{"key":"3194_CR30","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","volume":"357","author":"PJ Barter","year":"2007","unstructured":"Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M et al (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357:2109\u20132122","journal-title":"N Engl J Med"},{"key":"3194_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","volume":"371","author":"MJ Landray","year":"2014","unstructured":"HPS2-THRIVE Collaborative Group, Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, Wallendszus K, Craig M, Jiang L, Collins R, Armitage J (2014) Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med 371:203\u2013212","journal-title":"N Engl J Med"},{"key":"3194_CR32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1136\/ard.2010.135871","volume":"70","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Kremers HM et al (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482\u2013487","journal-title":"Ann Rheum Dis"},{"key":"3194_CR33","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","volume":"71","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK et al (2012) Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis 71:1157\u20131162","journal-title":"Ann Rheum Dis"},{"key":"3194_CR34","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1002\/art.24802","volume":"60","author":"C Charles-Schoeman","year":"2009","unstructured":"Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D et al (2009) Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 60:2870\u20132879","journal-title":"Arthritis Rheum"},{"key":"3194_CR35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","volume":"9","author":"J Robertson","year":"2013","unstructured":"Robertson J, Peters MJ, McInnes IB et al (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 9:513\u2013523","journal-title":"Nat Rev Rheumatol"},{"key":"3194_CR36","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2362.2008.01994.x","volume":"38","author":"C Garcia-Gomez","year":"2008","unstructured":"Garcia-Gomez C, Nolla JM, Valverde J, Narvaez J, Corbella E, Pinto X (2008) High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest 38:686\u2013692","journal-title":"Eur J Clin Invest"},{"key":"3194_CR37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/rheumatology\/kes353","volume":"52","author":"JA Avi\u00f1a-Zubieta","year":"2013","unstructured":"Avi\u00f1a-Zubieta JA, Abrahamowicz M, De Vera MA et al (2013) Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology 52:68\u201375","journal-title":"Rheumatology"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3194-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3194-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3194-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:28Z","timestamp":1559028508000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3194-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,25]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["3194"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3194-9","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,25]]}}}